Epigenomics AG
Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Its lead product is Epi proColon, a blood-based test for the early detection of colorectal cancer in the United States, Europe, and China. The co…
Medical - Diagnostics & Research
DE, Berlin [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peer Group Analysis
Similar Stocks · Benchmarked Analysis · Peer GroupA quick analysis that compared Epigenomics AG (EPGNF) to it's peer group, including competitors as well as it's industry. All monetary values in mil. except volume - volume is in thousands.
| Company | Price | Change | Volume, Avg. | Market Cap. | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diagnostics & Research Average | - - | - - | - - | 68,221.67 | 1,979.81 | 249.95 | 8,993.05 | 257.86 | 0.00 | 17.1442 | 1.46 | 0.4173 | 0.0105 | 0.00 | -0.06 | 1.4842 | - - | ||
| Maximum | - - | - - | - - | 916,755.00 | 10,345.00 | 1,328.00 | 48,542.00 | 1,448.00 | 0.01 | 122.5004 | 8.28 | 0.7332 | 0.2444 | 0.07 | 0.15 | 6.8693 | - - | ||
| Minimum | - - | - - | - - | 30.00 | 19.00 | -110.00 | -3,579.00 | -163.00 | 0.00 | -299.9607 | -1.63 | -0.0242 | -0.5241 | -0.07 | -1.12 | 0.5844 | - - | ||
| Qiagen N.V. QGEN | 42.33 | 0.24 0.57% | 783 vs. 1,218 | 9,390.00 | 458.00 | 80.00 | 94.00 | 2,486.00 | 0.3600 | 29.2114 | 0.0000 | 0.6283 | 0.1758 | 0.0224 | 0.0139 | 1.2067 | 221.00 | ||
| Sotera Health Company SHC | 12.41 | -0.80 -6.06% | 2,712 vs. 1,279 | 3,514.00 | 248.00 | 6.00 | -26.00 | -648.00 | 0.0223 | 130.4121 | 0.0000 | 0.4488 | 0.0255 | 0.0147 | 0.0021 | 2.6565 | 283.00 | ||
| Neogen Corporation NEOG | 14.58 | -0.32 -2.15% | 1,376 vs. 1,507 | 3,159.00 | 228.00 | -2.00 | -62.00 | 561.00 | -0.0093 | -460.3506 | 0.0000 | 0.5108 | -0.0088 | -0.0006 | -0.0004 | 2.1669 | 216.00 | ||
| Illumina, Inc. ILMN | 136.99 | 5.31 4.03% | 1,966 vs. 1,805 | 21,726.00 | 1,076.00 | -126.00 | 41.00 | -145.00 | -0.7900 | -41.8700 | 0.0000 | 0.6199 | -0.1171 | -0.0220 | -0.0125 | 1.1974 | 158.00 | ||
| Guardant Health, Inc. GH | 30.98 | 0.30 0.98% | 1,677 vs. 2,113 | 3,827.00 | 168.00 | -114.00 | -37.00 | -2,256.00 | -0.9400 | -5.3587 | 0.0000 | 0.6125 | -0.6824 | -1.6839 | -0.0675 | 5.5171 | 123.00 | ||
| Syneos Health, Inc. SYNH | 42.98 | 0.01 0.02% | 6,703 vs. 1,323 | 4,457.00 | 1,366.00 | 0.00 | -51.00 | 96.00 | 0.0100 | 1386.2094 | 0.0000 | 0.2157 | 0.0006 | 0.0002 | 0.0001 | 1.0950 | 103.00 | ||
| Natera, Inc. NTRA | 169.36 | 1.48 0.88% | 1,285 vs. 1,223 | 22,359.00 | 367.00 | -67.00 | 6.00 | -2,445.00 | -0.5600 | -41.5349 | 0.0000 | 0.5672 | -0.1838 | -0.0851 | -0.0460 | 3.8297 | 132.00 | ||
More Due Diligence
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.